Abstract | Fungal aromatic polyketides constitute a large family of bioactive natural products and are synthesized by the non-reducing group of iterative polyketide synthases (PKSs). Their diverse structures arise from selective enzymatic modifications of reactive, enzyme-bound poly-β-keto intermediates. How iterative PKSs control starter unit selection, polyketide chain initiation and elongation, intermediate folding and cyclization, selective redox or modification reactions during assembly, and product release are central mechanistic questions underlying iterative catalysis. This Review highlights recent insights into these questions, with a particular focus on the biosynthetic programming of fungal aromatic polyketides, and draws comparisons with the allied biosynthetic processes in bacteria.
Polyketide natural products possess great commercial value owing to their diverse biological activities, which result from the structural variation that is implemented during their synthesis by polyketide synthases (PKSs). The fungal polyketide statins, such as lovastatin (compound 1; FIG. 1a) , for example, are among the most successful cholesterol-lowering agents on the market. Bacterial polyketides (FIG. 1a) such as the tetracycline (compound 4) antibiotics or the daunomycin (compound 5)-inspired doxorubicin anti-cancer agents have been prescribed for decades. Fungal polyketide mycotoxins (FIG. 1) , including aflatoxin B1 (compound 10), fumonisin B1 (compound 2), zearalenone (compound 3) and the 6-methylsalicylic acid (compound 6)-derived patulin (compound 7), have a profoundly negative effect on agriculture. Like the bacteria-derived tetracyclines or daunomycins, the fungal aromatic polyketides (secondary metabolites that are often toxic) share structural features that reflect similarities in their biosynthetic origins (FIG. 1b) . Understanding how polyketide structural variation is generated will be the key to identifying and predicting new products that are encoded in the vast number of emerging sequenced microbial genomes and to developing new bioactive polyketides through rational pathway or enzyme engineering.
PKSs use chemistry that is common to that used in fatty acid biosynthesis 1, 2 (FIG. 2) . Short-chain fatty acids, activated as their CoA esters, are used as starter units (for example, acetyl-CoA) and extender units (for example, malonyl-CoA) and are homologated to form linear chains, such as the C 16 fatty acid palmitate, through effective decarboxylative Claisen condensations (involving hydration of malonyl-ACP (acyl-carrier protein) and its loss of bicarbonate 3 ). In the case of fatty acid synthases (FASs) and PKSs, the acyl transacylase (AT) loads the starter and extender units in turn onto an ACP, which carries the intermediates through the catalytic cycle. The ketosynthase (KS) accepts the acyl starter unit from the ACP via transthioesterification and subsequently condenses malonyl-CoA units that are shuttled by the ACP onto the starter unit to add a ketide unit one catalytic step at a time. In fatty acid biosynthesis, the resulting β-ketone is fully reduced by stepwise ketoreductase (KR), dehydrase (DH) and enoyl reductase (ER) reactions to produce an inert hydrocarbon chain. In polyketide biosynthesis, full reduction does not always occur at the β-carbon of the extending chain, and the PKSs selectively use these reductive and/or dehydrative processing steps to introduce one of the four possible chemical states (ketone, hydroxyl, alkene or saturated methylene) at the β-carbon during polyketide assembly. In some cases, PKS systems recruit additional auxiliary enzymes or domains to carry out specialized reactions. All of these biosynthetic steps can be programmatically varied to produce a vast array of structural outcomes. Likewise, the absence of reduction steps leads to poly-β-keto chains that can be folded and cyclized in different ways to produce the many different scaffolds that are found in aromatic polyketides.
PKSs have been the subject of extensive review and are currently divided into three general classes (type I 1, 4 , type II [5] [6] [7] and type III [8] [9] [10] ) 11, 12 , although the exchange and evolution of genetic information among organisms has led to mixed classes in some cases 13, 14 . generally multidomain systems (type I PKSs; BOX 1) that elongate their polyketide products iteratively. Unlike the bacterial type I PKSs, which are often modular megasynthases that produce products such as erythromycin in a predictable assembly-line fashion, the iterative fungal type I systems reuse a single set of active sites through multiple catalytic cycles. Iterative type I PKSs are further subdivided according to the level of reductive processing that occurs during chain assembly (non-reducing (nR), partially reducing 15 or highly reducing 16 PKSs) 17, 18 . whereas fungal aromatic PKSs are type I nR-PKSs, bacterial aromatic PKSs are discretely expressed, free-standing proteins (type II) that associate to carry out the required chemistry. Regardless of whether the chemistry occurs in a single multidomain protein or in a multi-enzyme complex, aromatic PKSs must all contend with reactive poly-β-keto intermediates, controlling their chain length, folding and cyclization as well as product release.
over the past 5 years, our understanding of fungal aromatic-polyketide biosynthesis has advanced greatly. Here, we review the latest progress, including our increased understanding of starter unit selection, chain length control and cyclization specificity. These advances should provide the foundation for many discoveries ahead as more complex PKSs begin to reveal their biosynthetic programming codes. Enzyme deconstruction multidomain proteins are common in nature and are most often thought to be the result of evolutionary fusion events between smaller ancestral genes. Before the advent of PCR-based molecular approaches, partial proteolysis of multidomain proteins was the primary method used to obtain the individual catalytic domains for further study 19 . These classical approaches were important for the study of animal FASs 20 -close relatives of the fungal PKSs. Domains from animal FASs could be reacted with their free-standing bacterial FAS type II counterparts to assess enzymatic activity and, consequently, to further support their evolutionary relationships 21 . To that end, the Townsend laboratory developed a bioinformatics-based method, the Udwary-merski algorithm, which combines sequence similarity, predicted secondary structure conservation and local hydrophobicity to predict the location of the linker regions between catalytic domains in large multifunctional proteins such as PKSs 22 . Application of this algorithm to the nR-PKS group predicted six well-defined domains (FIG. 2a) . Four were readily identified by sequence conservation with known proteins (the KS domain, the malonyl-CoA-ACP transacylase (mAT) domain, the ACP domain and the terminal thioesterase-Claisen cyclase (TE-CLC) domain), but the other two domains, a long aminoterminal domain and a centrally located domain, lacked significant sequence conservation to any known enzyme. The central domain was termed the product template (PT) domain on the basis of its location adjacent to the ACP and the proposal that it is required for chemical stabilization of reactive poly-β-keto intermediates 22 . This in silico approach greatly accelerated efforts to clone and isolate individual domains or combinations of properly folded domains from various fungal polyketide systems for biochemical deconstruction -that is, domain dissection and in vitro reconstitution studies [23] [24] [25] [26] [27] [28] [29] . others have used the sequence conservation of the type II bacterial enzymes or other structurally characterized proteins to successfully select sites at or near predicted domain boundaries for further biochemical interrogation [30] [31] [32] .
The biochemical basis for starter unit selection Since the discovery in 1955 that radiolabelled acetate was incorporated into the now-archetypal fungal polyketide 6-methylsalicylic acid in Penicillium griseofulvum 33 , many groups have used isotopic labelling studies with the aim of understanding polyketide biosynthesis in both eukaryotes and bacteria. Beginning in the 1950s, 14 C-labelled acetate or malonate was administered to fungal or bacterial cultures, and the sites of radioisotope incorporation in the resulting polyketides were carefully tracked by chemical degradation 34 . Radiotracer methods were later replaced by nmR techniques using various . These domains are, in order: the starter unit-ACP transacylase (SAT), the ketosynthase (KS), the malonyl-CoA-ACP transacylase (MAT), the product template (PT), the acyl-carrier protein (ACP), and the thioesterase-Claisen cyclase (TE-CLC) domains. b | The growing substrates are passed back and forth between the KS and the ACP by thioester transfers (enz stands for the KS or ACP domain). The acyl transacylase (AT) loads the ACP from starter or extender acyl-CoA substrates. Product complexity arises from the number of cycles (chain length control) and the selective reductive processing that can be carried out during product assembly by a ketoreductase (KR), dehydrase (DH) or enoyl reductase (ER). The TE is often used to terminate the programme and release the final product. Type II PKSs are free-standing proteins, one for each enzymatic function, that associate to form a multi-enzyme complex, whereas type I PKSs are fused into single multidomain proteins.
Non-ribosomal peptide synthetase
A large modular enzyme that produces a broad range of peptide-based bioactive secondary metabolites. stable isotopic labels ( 13 C, 18 o, 15 n, 2 H) and, consequently, a large body of isotopic-labelling data has accrued over the years. The central dogma arising from more than 60 years of these studies posits that fungal PKSs typically select acetyl-CoA as the starter unit to initiate biosynthesis rather than malonyl-CoA, and this has come to be known as the acetyl 'starter unit effect' (reFS 23, 25, 35, 36) . Current efforts have focused on correlating these labelling trends with the underlying biosynthetic enzymes in bacteria and fungi.
PKSs can accept starter units that are more complex than acetyl, particularly when they are downstream of other PKSs or associated with other biosynthetic systems, such as non-ribosomal peptide synthetases (nRPSs), FASs and terpene biosynthesis enzymes. For example, biosynthesis of the fungal polyketide aflatoxin in select Aspergillus species 37-39 involves an nR-PKS (PksA; also known as AflC 40 ) in a FAS-PKS hybrid complex 41, 42 . The nR-PKS accepts a C 6 fatty acid starter unit 43-45 from a dedicated fungal FAS 26, 46, 47 , further homologates seven malonylCoA extender units and controls specific folding and cyclization to produce the aflatoxin B1 (compound 10) precursor, norsolorinic acid anthrone (compound 8) (FIG. 1b) . The anthrone is oxidized by an anthrone oxidase to the anthraquinone norsolorinic acid (compound 9;
FIG. 1b) 48 . Approximately 15 further enzymatic steps, including several complex oxidations, are required to form the highly rearranged structure of aflatoxin B1 (reF. 37). The aflatoxins are potent environmental procarcinogens that commonly contaminate agricultural foods, and chronic ingestion of these compounds and their subsequent oxidation and activation in the liver and kidney can lead to hepatocellular and renal carcinoma 49 . Functional interrogation of PksA led to the elucidation of a biochemical rationale for the starter unit effect in fungal nR-PKSs 23 . The long amino-terminal domain in nR-PKSs has minimal sequence conservation with enzymes of known function but has predicted secondarystructure similarity to mAT domains. Kinetic analyses and mutation experiments revealed that this domain is responsible for accepting the hexanoyl starter unit from the associated FAS to initiate polyketide biosynthesis 23 . This unusual domain uses thioester chemistry, as opposed to the oxyester chemistry found in typical AT domains, and so was termed the starter unit-ACP transacylase (SAT) domain. It was proposed that when associated proteins, such as the dedicated FAS proteins in aflatoxin biosynthesis, were absent, the SAT domain could mediate acetyl incorporation, thus providing a biochemical basis for the classical acetyl starter unit effect 23 . Indeed, the SAT domains involved in the biosynthesis of the naphthopyrone YwA1 (compound 12), tetrahydroxynaphthalene (compound 14), cercosporin (compound 15) and bikaverin (compound 16) (FIG. 1b) are selective for acetyl-CoA rather than malonyl-CoA or other longer-chain acyl-CoA substrates 25 .
The Gibberella fujikuroi nR-PKS for bikaverin synthesis 50 was produced in Escherichia coli, and the purified protein could use malonyl-CoA, rather than acetyl-CoA, as a starter unit in vitro to produce the bikaverin precursor (compound 20; FIG. 3) 
51
. The catalytic cysteine residue of the SAT domain of this nR-PKS was not predicted to be encoded by the annotated G. fujikuroi gene sequence. However, re-sequencing of this SAT region led to the discovery of a frameshift and an alternatively spliced form that translates through the active-site cysteine in G. fujikuroi 25 . The encoded domain in this corrected protein was indeed selective for acetyl-CoA 25 . Recent in vivo versus in vitro comparisons with the lovastatin PKS show that, like other fungal PKSs, acetyl-CoA is preferentially accepted by this PKS in vivo, whereas malonyl-CoA can be accepted in vitro 52 . The conservation of acetylCoA starter unit specificity in fungal PKSs is probably a result of the metabolic benefits of sampling this readily available tricarboxylic acid cycle precursor rather than converting it to malonyl-CoA.
In addition to accepting short-and medium-chain fatty acids, SAT domains have since been implicated in accepting other substrates. This was recently demonstrated biochemically 53 for the advanced intermediates of resorcylic acid lactones 24, [54] [55] [56] [57] . Given that nR-PKS genes are ubiquitous in filamentous fungi, and multiple homologues are often encoded by a single genome, substrate selectivity at the SAT domain provides a means of using alternative starter units to generate the structural variation found in aromatic polyketides 24 .
Control of reactive poly-β-keto intermediates one approach to deconstructing PKS function has been to dissect the full-length enzyme into individual catalytic domains or small groups of adjacent domains for in vitro reconstitution experiments. Initial experiments aimed at understanding how nR-PKSs control the formation and subsequent processing of poly-β-keto intermediates were also carried out using PksA. By analysing both the intermediates directly tethered to the ACP domain and the products released by PksA, the global division of labour among the individual domains in the iterative catalytic cycle was defined 27 . Domain combinations lacking the ACP did not assemble detectable released products, confirming the crucial role of this domain in carrying intermediates during polyketide extension and processing. when the ACP domain was present but lacked the necessary tailoring domains, a stalled linear poly-β-keto intermediate (compound 17; FIG. 3) was detected, and subsequent tandem mass spectrometry (mS/mS) fragmentation analysis confirmed the suggested structure, providing the first direct experimental evidence for these long-proposed enzyme-bound intermediates (FIG. 3) .
Box 1 | Polyketide synthases
Type I polyketide synthases (PKSs) are multidomain enzyme systems. Individual domains can be used once in a modular 'assembly line' manner (modular type I systems), or they can be reused multiple times during product assembly in an iterative manner (iterative type I systems). Fungal PKSs are often iterative type I systems. Type II PKSs are free-standing proteins that associate to carry out their chemistry. Bacterial aromatic PKSs are type II iterative systems. Type III PKSs are single proteins found in plants, bacteria and fungi. They resemble the ketosynthase domain or protein found in type I and type II PKSs, but they use acyl-CoA substrates directly in an iterative manner without the requirement for any auxiliary enzymes. Because the SAT 23 and mAT 30 domains load the starter and extender units, respectively, and the ACP domain carries the elongated intermediates through the catalytic cycle, it was proposed that the KS domain is mostly, if not entirely, responsible for controlling the chain length of the poly-β-keto intermediate 27 .
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In support of this notion, the minimal nR-PKS components (the KS, mAT and ACP domains) from the bikaverin (compound 16) PKS system of G. fujikuroi (Pks4), primarily produce an intermediate of the correct chain length but lack the ability to control cyclization chemistry 32 . moreover, non-cognate ACP domains 30 and the mAT proteins from FASs 7 can often qualitatively complement the activity of aromatic-polyketide biosynthesis. The solution structure of the PksA ACP domain exhibited minimal interaction with a tethered non-polar acylthioester substrate 58 , further narrowing chain length control to the KS domain. non-natural starter units with different chain lengths alter the number of ketide extensions to reflect the natural chain length, which is probably dictated by the available KS cavity volume 51 . In the bacterial type II PKSs, chain length is controlled by KS (KSα) and chain length factor (also known as KSβ; type I nR-PKS systems lack this factor) 59 . when an active PT domain was added to the loading, carrier and KS domains, there was a decrease in the amount of linear substrate (compound 17) attached to the ACP domain, a reduction in unknown cyclization products and a marked increase in the correct cyclization of rings A and B (compound 18; FIG. 3) , and norpyrone (compound 11; FIG. 1b) was detected as the major product 27 . The PksA PT domain is responsible for accepting the fully extended linear polyketide intermediate and catalysing its stepwise cyclization and aromatization to produce the penultimate polyketide intermediate (compound 18) . when the full complement of all six domains was present, the correct final cyclization outcome was observed. The TE-CLC domain catalysed C-C bond closure -as opposed to spontaneous o-C bond derailment -leading to the release of norsolorinic acid anthrone (compound 8), which is subsequently oxidized to norsolorinic acid (compound 9) on the path to aflatoxin 27 (FIG. 3) .
It was evident from these experiments that domain fusion enhances catalytic efficiency, which undoubtedly constitutes an evolutionary basis for the formation of the iterative type I systems in eukaryotes 27 . Heterologous coexpression of individual fungal domains has not led to readily observable chemistry, mandating that direct covalent linkage or engineered linker peptides are required for efficient production in vivo 32, 60 . nevertheless, dissected domains that are reconstituted in vitro maintain the ability to faithfully interact in trans to enable polyketide formation, similarly to the iterative type II bacterial systems. The gene encoding the nR-PKS 
Directed evolution
Accelerated evolution and natural selection in the laboratory to achieve modified enzyme properties.
responsible for the biosynthesis of bikaverin (compound 16) was expressed in E. coli for in vitro biochemical analysis 51 , and subsequent experiments showed that non-cognate bacterial proteins (a KR and an aromatase/ cyclase (Aro/Cyc) that is known to catalyse cyclization in bacterial aromatic-polyketide biosynthesis) and the dissected fungal TE-CLC domain can interact in trans with the fungal PKS 61 . Intriguingly, it was shown that a free-standing bacterial type II KR that normally interacts with its cognate type II PKS could access the poly-β-keto intermediate generated by the fungal PKS and carry out regioselective reduction 61 . This suggests that, despite the evolutionary separation of the bacterial and fungal enzymes, interspecies substrate recognition and proper protein-protein docking can still take place.
The ability to use non-cognate enzymes to carry out alternative reactions not only opens the door for the engineering of new product scaffolds, but also illustrates the ease of gene cluster diversification in the evolution of bioactive fungal aromatic metabolites. Unlike the exquisite specificity of the enzymes involved in primary metabolism, which is emblematic of the 'one substrate, one enzyme, one product' rule for metabolic fidelity, many of the enzymes involved in secondary metabolism show a greater tolerance. one enzyme can often accept multiple substrates to produce multiple products, or a common intermediate can diverge to multiple products, such as a series of antibiotics, that give the host a competitive advantage 62 . Such enzymes can be only a few mutations away from substrate promiscuity or alternative functions. Directed evolution is a powerful approach by which to engineer entirely new enzymatic specificities. In keeping with the promiscuity of individual biosynthetic enzymes, entire secondary-metabolite pathways are, in fact, diversity oriented 63 . The ability of alternative proteins or domains to act in trans clearly illuminates the evolutionary malleability of the iterative metabolite synthesis gene clusters of fungi.
Cyclization specificity of aromatic PKSs
The stable-isotope labelling patterns collected for polyketide metabolites not only supported the fungal starter unit effect, but also defined polyketide folding patterns -that is, how the PKSs regioselectively control polyketide geometry before cyclization and aromatization 64, 65 . In aromatic polyketides, multiple folding modes can lead to the same product. For example, the polyketide chrysophanol is produced by both fungi and bacteria, and although it is derived from a common poly-β-keto intermediate, it is cyclized differently in fungi (F-mode cyclization) and bacteria (S-mode cyclization) 66 . Recent structural and biochemical studies have revealed the underlying enzymatic basis for folding and cyclization.
The iterative PKSs in fungi are architecturally related to mammalian FASs. Indeed, the crystal structure of a mammalian FAS illustrates that this multidomain enzyme harbours an inactive methyltransferase domain that is closely related to domains found in reducing PKSs, indicating that this structural relic has been maintained from its ancestral origins in fungi 67 . Recent high-resolution crystal structures of the dimeric PT monodomain from PksA bound to mimics of linear or bicyclic substrates showed that, despite its low sequence conservation with known enzymes, the domain adopts a modified double hot dog fold 28 (FIG. 4a) . The double hot dog fold 68 has been observed in bacterial dehydrase-isomerases 69, 70 and mammalian hydratases 71 , as well as in the pseudodimeric dehydrase domains in mammalian FASs 67 . Interestingly, in the PT domains of nR-PKSs, this fold controls cyclization specificity, which is one of the key programmed steps in aromatic-polyketide biosynthesis 27, 28 . Furthermore, native PAGE mobility experiments on individual domains or combinations of domains from PksA showed that PT-domain-or KS-domaincontaining constructs exist as dimers, whereas the loading and tailoring domains occur as monomers 28 . Taken together, the observed associative interactions, the highresolution structural comparisons and the phylogenetic 72 and evolutionary relationships between fungal PKSs and animal FASs indicate that these enzymes are intriguingly similar but catalyse different synthetic outcomes.
The modified double hot dog fold of the PT domain of PksA dictates the cyclization outcome 28 . The substratebinding regions of this domain can be divided into three sections: the phosphopantetheine-localization channel, which binds the extended phosphopantetheine arm of the ACP domain that delivers the linear intermediate into the interior binding pocket; the central cyclization chamber, which promotes cyclization of the delivered substrate and accommodates the cyclization products; and the hexyl-binding region, which lies deep in the protein core and binds the fatty acid starter unit (the PT hexyl-binding channel is thought to be closed in acetylinitiated systems). The linear arrangement of binding sites from the periphery to the protein core is aligned to hold the poly-β-keto intermediate in a nearly linear manner, centrally kinked into the cyclization chamber to initiate F-mode C4-C9 (FIG. 4b) and C2-C11 cyclizations. Intriguingly, the catalytic chemistry of the PT domain is influenced by distinct 'wet' and 'dry' sides of the cyclization chamber. Because the keto form, as opposed to the enol form, is favoured in water 73, 74 , the wet side of the cyclization chamber ensures that the substrate is in the electrophilic keto form for cyclization, and the resulting cyclized product is then displaced into the dry, hydrophobic reaction chamber by a thermodynamic driving force afforded by C-C bond formation, loss of water and aromatization 28 . The counterpart bacterial Aro/Cyc protein from the biosynthetic pathway for the antibiotic tetracenomycin adopts a topologically related helix-grip fold that is thought to bind its poly-β-keto substrate in a distinct hairpin conformation and to drive S-mode C9-C14 and C7-C16 cyclizations 75 . Aro/ Cyc proteins are thought to have evolved from ancient ligand-binding proteins 76 , whereas PT domains are thought to have evolved from DH domains in ancient reducing PKSs 28 . The different evolutionary paths and structural topologies of eukaryotic PT domains and bacterial Aro/Cyc proteins have resulted in the altered chemistry that is seen across the kingdoms, and it is likely that the wet-dry active-site arrangement in PT domains is common in enzymatic carbonyl-based chemistry. 
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Macrolactamization
The act of cyclizing to a macrocycle by formation of an amide (lactam).
It has been proposed, on the basis of phylogenetic analysis, that chain length control might be facilitated by the PT domain 77 , although the apparent relationship between PT clade structure and chain length is more likely to be correlated to the cavity volume 17 and cyclization mode that are required to accommodate the mature linear intermediates 27 . Comparison of active-site residues between the known C4-C9 and C2-C7 first-ring-cyclizing PT domains showed that there are distinct sequences for each of the two cyclization modes 28 . Subsequent phylogenetic studies illustrated that PT domains fall into five groups on the basis of their cyclization specificity and the number of rings in the final product 60 . The putative group of C6-C11-cyclizing PT domains was verified by incorporating the PT domains (C6-C11) used for the synthesis of asperthecin 78 or viridicatumotoxin 79 into the minimal PKS (KS, mAT and ACP domains) from the bikaverin biosynthetic pathway (which uses a C2-C7 PT domain) 60 . In these studies, chain length was again set before cyclization, and the regiospecificity was altered by the introduced PT domain. The clade structure of the individual PT domains 60 , in addition to common active-site residues 28 Claisen condensation governs product release PKSs have acquired several strategies to terminate the biosynthetic programme and release their final products 80 . The canonical strategy for PKSs and FASs is TE-mediated product release. TEs are capable of catalysing not only simple hydrolysis, macrolactonization and macrolactamization reactions, but also Claisen cyclization/ Dieckmann C-C bond-forming condensation reactions in nR-PKSs. The first report of a TE-CLC domain was obtained from the Aspergillus nidulans nR-PKS responsible for biosynthesis of the heptaketide naphthopyrone spore pigment YwA1 (compound 12). Asexual spores, or conidia, produce pigments that contribute to the strength, rigidity and impermeability of their cell walls. Using heterologous expression of the YwA1 nR-PKS in Aspergillus oryzae and subsequent product analysis, wA was identified as the protein responsible for biosynthesis of YwA1 (reF. 81) . wA was originally thought to produce citreoisocoumarins (o-C cyclization products rather than the correct TE-CLC C-C cyclization product) owing to an unintentional deletion of the carboxy-terminal TE domain that occurred during the study 82 . This fortuitous deletion, coupled with site-directed mutagenesis in the TE domain, later led to the identification of a new class of TE-CLC domains that catalyse C-C bond cyclization as opposed to the simple hydrolysis or macrocyclizations previously reported in TE domains 83 . TE-CLC activity has since been identified in other nR-PKSs that are responsible for the synthesis of tetrahydroxynaphthalene (compound 14) 84 , bikaverin (compound 16) 61 and norsolorinic acid anthrone (compound 8) 27, 29 . The open form of the pigment YwA1 (compound 12′) can serve as a substrate for melanin biosynthesis through a hydrolytic chain-shortening reaction to tetrahydroxynaphthalene (compound 14) 85 (FIG. 3) . The protein Ayg1 catalyses this retro-Claisen reaction.
Since the early 1960s, fungi have been known to produce melanins. In addition to contributing to cell wall integrity 86 , melanins are known to act as virulence factors in human and plant pathogens 87, 88 . They have been reported to have antioxidant and antiphagocytic properties, to contribute to cAmP-dependent signalling and to block antimicrobial entry. Even though they have such important physiological roles, the mechanistic and biochemical bases for the biosynthesis of polyketide monomer units of melanin have only emerged in the past few years. Identification of the nR-PKS responsible for the production of the monomer unit in Colletotrichum lagenarium was confirmed by heterologous expression of the C. lagenarium PKS1 in A. oryzae followed by product analysis 89 . In this expression system, tetrahydroxynaphthalene (compound 14), a precursor to the monomer unit found in dihydroxynaphthalene-based melanin, was the main product observed, accounting for 50% of the total product 84 . minor products were also present, including acetyl-tetrahydroxynaphthalene (compound 13 (FIG. 1b) ; accounting for 15% of the product). Partial purification of Pks1 and feeding studies with radiolabelled acetylCoA and malonyl-CoA precursors showed that radioactivity from malonyl-CoA, but not from acetyl-CoA, remained in the symmetrical tetrahydroxynaphthalene product, and the authors proposed that acetyl-CoA was not used as a starter unit 90 . Similar labelling trends were discovered for scytalone biosynthesis in the early 1980s. Scytalone is derived from tetrahydroxynaphthalene, but an alternative biosynthesis pathway was proposed on the basis of the general acetyl 'starter unit effect' trends that were known at the time 91 . It was suggested that either the acetyl starter unit could not be detected under the experimental conditions used or the product could be derived from a hexaketide precursor (compound 19; FIG. 3 ) that loses its acetyl starter unit in the formation of the pentaketide tetrahydroxynaphthalene. mutagenesis of the carboxy-terminal TE-CLC domain led to the production of the hexaketide isocoumarin (>95% of the produced products were isocoumarin o-C cyclization derailments) as opposed to the pentaketide tetrahydroxynaphthalene (a C-C cyclization product) 84 , indicating that the nR-PKS was probably a hexaketide synthase, but it was instead suggested that the TE-CLC domain controls chain length. Because doubts remained over the biosynthetic origins of tetrahydroxynaphthalene, the substrate preference of the SAT domain in Pks1 was analysed and it was found to be selective for acetyl-CoA but not malonyl-CoA 25 . Based on these and previous results, a unified biosynthetic pathway was proposed in which acetyl-CoA is incorporated into the hexaketide acetyl-tetrahydroxynaphthalene (compound 13; FIG. 3) , and an Ayg1-mediated hydrolytic chain-shortening reaction could then occur, as had been found for YwA1. Indeed, a knockout of the Ayg1 homologue in Wangiella dermatitidis later confirmed that a Pks1 homologue produced acetyl-tetrahydroxynaphthalene 92 and that the enzyme could catalyse the retro-Claisen reaction in vitro 93 . The same phenomenon has yet to be confirmed experimentally for the C. lagenarium Pks1 system. It is also important to note that, because malonyl-ACP can be decarboxylated, it is possible that malonyl-CoA can partially contribute to starter unit initiation in fungal polyketide synthesis. The effects are likely to vary according to growth conditions and the kinetic parameters of the individual loading domains in PKS homologues.
The PksA TE-CLC monodomain crystal structure was solved to 1.7 Å resolution, and the structure displayed the typical α/β-hydrolase fold in the catalytic closed form 29 (FIG. 5a) . why would nature evolve to use an enzyme fold that is widespread and well known to drive o-C bond formation 94 , when that is exactly the reaction that must be prevented in the Claisen-type (C-C bond formation) product release mechanism? Indeed, the TE-CLC domain has maintained its ability to catalyse hydrolysis (o-C bond formation), which probably serves an editing function in the absence of the correct Claisen cyclization substrate 22, 29 . Removal of the TE-CLC domain or individual mutation of the catalytic triad residues (analogous to the serine protease triad Ser. . His. . Asp 95 ) destroys both the hydrolytic and C-C bond-forming abilities of the protein, leading to spontaneous product derailment as the o-C-cyclized norpyrone (compound 11) 27, 29 . The key to the native reaction lies in the lid loop, which is the gateway to the catalytic core of the enzyme. The major difference among the known TE-CLC domain structures is in this region. Docking of the ACP domain, with its tethered intermediate, to the TE-CLC domain presumably induces a conformational change to open the lid for substrate entry. Supporting this notion, nmR titration experiments suggest that the analogous region of the TE domain interacts with its peptidyl carrier protein in enterobactin biosynthesis 96, 97 . Based on the catalytic closed-form structure of the TE-CLC domain, the phosphopantetheine arm in the ACP domain must leave the pocket before the lid loop can close 29 (FIG. 5b) . The substrate side-chain swings into the space vacated by the departing arm, and when the lid closes, the substrate side chain is locked into the correct position adjacent to the catalytic histidine residue to facilitate C-C bond formation. The hydrophobic binding chamber and lid impose strict substrate positioning, which is the structural basis for regiospecific product release by C-C bond formation and for programme termination in fungal aromatic-polyketide biosynthesis.
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Conclusions
Until recently, the fungal iterative PKSs have eluded detailed biochemical investigations because of their large size and the lack of microbiological tools to produce these enzymes in experimentally useful quantities 11 . The development of gene expression methods and the evolutionary relatedness of nR-PKSs to the well-studied animal FASs have greatly accelerated our understanding of iterative enzyme catalysis. The domains of type I iterative PKSs and the free-standing auxiliary proteins that interact with fungal PKSs must bind and accommodate substrates of increasing length, harbour compatible protein-protein interaction surfaces and maintain favourable kinetics to channel the elongating product to a specific structural outcome. The ACP domain docks efficiently with its client domains in these large synthases to covalently shuttle the growing intermediates through the many biosynthetic steps at high effective substrate concentrations. The multidomain type I systems enjoy the same kinetic benefits from the covalent interactions (linkers) that have been formed by evolutionary domain fusion events 27, 98 . The linker regions seem not to interfere with programming, as activity remains normal in vitro when the linkers are truncated or replaced by His 6 -fusion tags.
Because multidomain systems have evolved by fusion events, it is not surprising (but fortunate, experimentally) to see that wild-type catalytic chemistry can be faithfully executed by the dissected, free-standing domains. PKSs illustrate the fact that the fundamental chemical potential held by a handful of protein folds can be exploited in different ways to take on new functions. The fundamental chemistry and protein folds in PT domains, for example, are similar to those of DH domains in animal FASs, but the double hot dog fold has been modified to expand the repertoire of carbonyl chemistry to allow control of the cyclization specificity by fungal aromatic PKSs.
Individual domains or trans-acting auxiliary enzymes seem to be qualitatively interchangeable, and the future manipulation of iterative enzymes will be a balancing act between enzyme tolerance and specificity. Even though fungal nR-PKSs have solved the daunting chemical tasks of controlling the synthesis and cyclization of highly reactive poly-β-keto intermediates, they execute an other wise simple biosynthetic programme, in that no reductive processing steps occur during assembly. The fact that domains or accessory enzymes can act in trans to access the growing intermediates and selectively modulate activity provides a basis for understanding more complex iterative PKS programming. The partially reducing and highly reducing iterative PKSs in fungi can carry out selective redox or methylation reactions during assembly to increase the structural diversity of the products. Presumably, similar forces are at work here to modulate the biosynthetic programming of these enzymes and to direct the biochemical outcome. In the pioneering work of Hutchinson, vederas and co-workers, for example, it was found that a trans-acting ER auxiliary protein was necessary to complement the highly reducing PKS lovastatin nonaketide synthase (LnKS) to correctly produce the lovastatin precursor 99 . when the ER protein was lacking, LnKS exhibited aberrant activity in vivo. The free-standing ER was subsequently shown in vitro to hold a gatekeeper function to modulate LnKS activity 52 . It is likely that such interactions are more commonly required to process reduced polyketides, and auxiliary enzymes will be required to obtain on-path products in future heterologous expression or in vitro biochemical experiments 100 . Similar biochemical approaches will undoubtedly provide more insights into these more complex iterative PKSs.
Filamentous fungi produce many secondary metabolites with biomedical potential, and fungal genome projects indicate that they can produce many more [101] [102] [103] [104] . Single hosts have been reported to contain as many as 30 PKSs located in secondary metabolic gene clusters. of these, there are often multiple homologues in the nR-PKS group, and they are not redundant. Consequently, there are great opportunities for combining genomics with natural-product discovery in filamentous fungi. The tight regulatory control of the biosynthetic pathways involved often restricts the expression levels, which hinders attempts to isolate and characterize the encoded products 105 . Although such regulation is not surprising, as it allows the conservation of metabolic resources during times when the pathway is not required, it begs the question: what unknown signals are required to activate expression of
